Price $132.63 |
Market Cap
352.43B
|
Sector Health Care |
Div. Growth
6.20%
|
|
P/E
22.3
|
P/B
-
|
P/S
-
|
Dividend %
2.50%
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-
|
FCF
-
|
|
Op. Margin
27.50%
|
Net Margin
22.50%
|
ROE
-
|
ROI
17.00%
|
|
ROA
-
|
EPS Growth
10.10%
|
Current Ratio
2.5
|
Debt/Equity
31.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Encision Inc (ECIA) | $0.43 | - | - | 4.4M | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.71 | - | - | 15.5M | Strong Buy |
| Senomyx Inc. (SNMX) | $0.60 | - | - | 37.1M | Strong Buy |
| Valeant Pharmaceuticals Intl I (VRX) | $14.39 | - | - | 5.95B | Strong Buy |
| Catasys, Inc. (CATS) | $5.09 | - | - | 68.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
